Glucagon-like peptide-1 (GLP-1) receptor agonist prevents development of tolerance to anti-anxiety effect of ethanol and withdrawal-induced anxiety in rats. (Q47791067)

From Wikidata

Jump to navigation Jump to search

scientific article published on 8 November 2014

Language	Label	Description	Also known as
English	Glucagon-like peptide-1 (GLP-1) receptor agonist prevents development of tolerance to anti-anxiety effect of ethanol and withdrawal-induced anxiety in rats.	scientific article published on 8 November 2014

Statements

scholarly article

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/25380665

Glucagon-like peptide-1 (GLP-1) receptor agonist prevents development of tolerance to anti-anxiety effect of ethanol and withdrawal-induced anxiety in rats. (English)

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/25380665

author name string

Ajaykumar N Sharma

1

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/25380665

Ashish Pise

2

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/25380665

Jay N Sharma

3

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/25380665

Praveen Shukla

4

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/25380665

publication date

8 November 2014

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/25380665

Metabolic Brain Disease

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/25380665

30

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/25380665

3

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/25380665

719-730

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/25380665

https://scigraph.springernature.com/pub.10.1007/s11011-014-9627-z

0 references

Tolerance to ethanol sedation and withdrawal hyper-excitability is mediated via neuropeptide Y Y1 and Y5 receptors.

1 reference

https://api.crossref.org/works/10.1007%2FS11011-014-9627-Z

21 January 2018

Role of melatonin in the regulation of human circadian rhythms and sleep

1 reference

https://api.crossref.org/works/10.1007%2FS11011-014-9627-Z

21 January 2018

Amelioration of neurodegenerative changes in cellular and rat models of diabetes-related Alzheimer's disease by exendin-4

1 reference

https://api.crossref.org/works/10.1007%2FS11011-014-9627-Z

21 January 2018

Insulin and insulin-like growth factor resistance in alcoholic neurodegeneration

1 reference

https://api.crossref.org/works/10.1007%2FS11011-014-9627-Z

21 January 2018

Antipsychotic-like effect of GLP-1 agonist liraglutide but not DPP-IV inhibitor sitagliptin in mouse model for psychosis

1 reference

https://api.crossref.org/works/10.1007%2FS11011-014-9627-Z

21 January 2018

The glucagon-like peptide 1 analogue, exendin-4, attenuates the rewarding properties of psychostimulant drugs in mice

1 reference

https://api.crossref.org/works/10.1007%2FS11011-014-9627-Z

21 January 2018

The glucagon-like peptide 1 analogue Exendin-4 attenuates alcohol mediated behaviors in rodents.

1 reference

https://api.crossref.org/works/10.1007%2FS11011-014-9627-Z

21 January 2018

Diabetic db/db mice exhibit central nervous system and peripheral molecular alterations as seen in neurological disorders

1 reference

https://api.crossref.org/works/10.1007%2FS11011-014-9627-Z

21 January 2018

Liraglutide: from clinical trials to clinical practice

1 reference

https://api.crossref.org/works/10.1007%2FS11011-014-9627-Z

21 January 2018

Psychological and quality of life changes in patients using GLP-1 analogues.

1 reference

https://api.crossref.org/works/10.1007%2FS11011-014-9627-Z

21 January 2018

Glucagon-like peptide-1 in the rat brain: distribution of expression and functional implication

1 reference

https://api.crossref.org/works/10.1007%2FS11011-014-9627-Z

21 January 2018

Evaluation of GABAergic neuroactive steroid 3alpha-hydroxy-5alpha-pregnane-20-one as a neurobiological substrate for the anti-anxiety effect of ethanol in rats

1 reference

https://api.crossref.org/works/10.1007%2FS11011-014-9627-Z

21 January 2018

Drugs developed to treat diabetes, liraglutide and lixisenatide, cross the blood brain barrier and enhance neurogenesis

1 reference

https://api.crossref.org/works/10.1007%2FS11011-014-9627-Z

21 January 2018

Naltrexone (50 mg) plus psychotherapy in alcohol-dependent patients: a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1007%2FS11011-014-9627-Z

21 January 2018

Liraglutide: short-lived effect on gastric emptying -- long lasting effects on body weight

1 reference

https://api.crossref.org/works/10.1007%2FS11011-014-9627-Z

21 January 2018

Identification and functional characterization of melatonin Mel 1a receptors in pancreatic beta cells: potential role in incretin-mediated cell function by sensitization of cAMP signaling

1 reference

https://api.crossref.org/works/10.1007%2FS11011-014-9627-Z

21 January 2018

The relationship between anxiety disorders and alcohol use disorders: a review of major perspectives and findings.

1 reference

https://api.crossref.org/works/10.1007%2FS11011-014-9627-Z

21 January 2018

Anxiety mediates the association between anxiety sensitivity and coping-related drinking motives in alcoholism treatment patients

1 reference

https://api.crossref.org/works/10.1007%2FS11011-014-9627-Z

21 January 2018

Limitations on the use of benzodiazepines in anxiety and insomnia: are they justified?

1 reference

https://api.crossref.org/works/10.1007%2FS11011-014-9627-Z

21 January 2018

Acamprosate: recent findings and future research directions

1 reference

https://api.crossref.org/works/10.1007%2FS11011-014-9627-Z

21 January 2018

Hyperventilation, anxiety, craving for alcohol: a subacute alcohol withdrawal syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS11011-014-9627-Z

21 January 2018

Alcohol ingestion decreases both diurnal and nocturnal secretion of leptin in healthy individuals.

1 reference

https://api.crossref.org/works/10.1007%2FS11011-014-9627-Z

21 January 2018

Neurobiology of alcohol abuse

1 reference

https://api.crossref.org/works/10.1007%2FS11011-014-9627-Z

21 January 2018

Chronic progesterone treatment augments while dehydroepiandrosterone sulphate prevents tolerance to ethanol anxiolysis and withdrawal anxiety in rats.

1 reference

https://api.crossref.org/works/10.1007%2FS11011-014-9627-Z

21 January 2018

Neurobehavioral deficits in db/db diabetic mice

1 reference

https://api.crossref.org/works/10.1007%2FS11011-014-9627-Z

21 January 2018

Rosiglitazone treatment reversed depression- but not psychosis-like behavior of db/db diabetic mice.

1 reference

https://api.crossref.org/works/10.1007%2FS11011-014-9627-Z

21 January 2018

Common biological mechanisms between bipolar disorder and type 2 diabetes: Focus on inflammation

1 reference

https://api.crossref.org/works/10.1007%2FS11011-014-9627-Z

21 January 2018

Glucagon-like peptide 1 receptor induced suppression of food intake, and body weight is mediated by central IL-1 and IL-6

1 reference

https://api.crossref.org/works/10.1007%2FS11011-014-9627-Z

21 January 2018

Melatonin inhibits nitric oxide signaling by increasing PDE5 phosphorylation in coronary arteries

1 reference

https://api.crossref.org/works/10.1007%2FS11011-014-9627-Z

21 January 2018

Effect of maternal nutrient restriction and melatonin supplementation from mid to late gestation on vascular reactivity of maternal and fetal placental arteries.

1 reference

https://api.crossref.org/works/10.1007%2FS11011-014-9627-Z

21 January 2018

MT2 receptors mediate the inhibitory effects of melatonin on nitric oxide-induced relaxation of porcine isolated coronary arteries

1 reference

https://api.crossref.org/works/10.1007%2FS11011-014-9627-Z

21 January 2018

Neurosteroid allopregnanolone mediates anxiolytic effect of etifoxine in rats

1 reference

https://api.crossref.org/works/10.1007%2FS11011-014-9627-Z

21 January 2018

2011 and 2012 Early Careers Achievement Awards: Placental programming: how the maternal environment can impact placental function

1 reference

https://api.crossref.org/works/10.1007%2FS11011-014-9627-Z

21 January 2018

Animal models of alcohol's motivational effects.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25380665

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Agomelatine is effective in reducing insomnia in abstinent alcohol-dependent patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25380665

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Suppression of alcohol drinking with brain aldehyde dehydrogenase inhibition

1 reference

https://pubmed.ncbi.nlm.nih.gov/25380665

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dipeptidyl-peptidase IV (DPP-IV) inhibitor delays tolerance to anxiolytic effect of ethanol and withdrawal-induced anxiety in rats.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25380665

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravenous ghrelin administration increases alcohol craving in alcohol-dependent heavy drinkers: a preliminary investigation

1 reference

https://pubmed.ncbi.nlm.nih.gov/25380665

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lack of effect of exendin-4 and glucagon-like peptide-1-(7,36)-amide on insulin action in non-diabetic humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/25380665

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Benzodiazepines in the treatment of alcoholism

1 reference

https://pubmed.ncbi.nlm.nih.gov/25380665

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11011-014-9627-Z

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/25380665

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/25380665

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47791067&oldid=1442324710"